Buscar
01/01/2023
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)
Tesi N., Grenier-Boley B., Andrade V., Jansen I.E., Pedersen N.L., Stringa N., Zettergren A., Antonell A., Tankard R.M., Bis J.C., Sims R., Bellenguez C., González-Perez A., Macías J., Cervera-Carles L., Moreno F., Huerto Vilas R., García-Madrona S., Ullgren A., Naj A.C., Lemstra A.W., Pérez-Cordón A., Benussi A., Padovani A., Squassina A., de Mendonça A., Arias Pastor A., Kok A.A.L., Meggy A., Pastor A.B., Corma-Gómez A., Sanabria Á., DeStefano A.L., Schneider A., Haapasalo A., Kinhult Ståhlbom A., Tybjærg-Hansen A., Hartmann A.M., Spottke A., Borroni B., Arosio B., Nacmias B., Nordestgaard B.G., Kunkle B.W., Charbonnier C., Masullo C., Martínez Rodríguez C., Muñoz-Fernandez C., Dufouil C., Graff C., Ferreira C.B., Chillotti C., Reynolds C.A., Fenoglio C., Van Broeckhoven C., Clark C., Pisanu C., Satizabal C.L., Holmes C., Aarsland D., Rujescu D., Alcolea D., Galimberti D., Wallon D., Seripa D., Grünblatt E., Dardiotis E., Düzel E., Scarpini E., Conti E., Rubino E., Gelpi E., Rodriguez-Rodriguez E., Duron E., Boerwinkle E., Ferri E., Tagliavini F., Küçükali F., Pasquier F., Sanchez-Garcia F., Mangialasche F., Jessen F., Nicolas G., Selbæk G., Chêne G., Hadjigeorgiou G., Rossi G., Spalletta G., Giaccone G., Grande G., Binetti G., Papenberg G., Hampel H., Bailly H., Zetterberg H., Soininen H., Karlsson I.K., Alvarez I., Appollonio I., Giegling I., Skoog I., Saltvedt I., Rainero I., Rosas Allende I., Hort J., Diehl-Schmid J., Van Dongen J., Vidal J.-S., Lehtisalo J., Wiltfang J., Thomassen J.Q., Kornhuber J., Haines J.L., Vogelgsang J., Popp J., Deckert J., Buerger K., Morgan K., Fließbach K., Sleegers K., Molina-Porcel L., Kilander L., Weinhold L., Farrer L.A., Wang L.-S., Kleineidam L., Farotti L., Parnetti L., Tremolizzo L., Hausner L., Benussi L., Froelich L., Ikram M.A., Deniz-Naranjo M.C., Tsolaki M., Löwenmark M., Hulsman M., Spallazzi M., Pericak-Vance M.A., Esiri M., Bernal Sánchez-Arjona M., Dalmasso M.C., Martínez-Larrad M.T., Arcaro M., Nöthen M.M., Fernández-Fuertes M., Dichgans M., Ingelsson M., Herrmann M.J., Scherer M., Vyhnalek M., Kosmidis M.H., Yannakoulia M., Schmid M., Ewers M., Heneka M.T., Wagner M., Scamosci M., Kivipelto M., Hiltunen M., Zulaica M., Fornage M., Roberto N., van Schoor N.M., Seidu N.M., Banaj N., Armstrong N.J., Scarmeas N., Scherbaum N., Goldhardt O., Hanon O., Peters O., Skrobot O.A., Quenez O., Lerch O., Bossù P., Caffarra P., Dionigi Rossi P., Sakka P., Mecocci P., Hoffmann P., Holmans P.A., Fischer P., Riederer P., Yang Q., Marshall R., Kalaria R.N., Mayeux R., Vandenberghe R., Cecchetti R., Ghidoni R., Frikke-Schmidt R., Sorbi S., Hägg S., Engelborghs S., Helisalmi S., Botne Sando S., Kern S., Archetti S., Boschi S., Fostinelli S., Mendoza S., Mead S., Ciccone S., Djurovic S., Heilmann-Heimbach S., Riedel-Heller S., Kuulasmaa T., Lebouvier T., Polak T., Ngandu T., Grimmer T., Bessi V., Escott-Price V., Giedraitis V., Deramecourt V., Maier W., Jian X., Pijnenburg Y.A.L., Smith A.D., Saenz A., Bizzarro A., Lauria A., Vacca A., Solomon A., Anastasiou A., Richardson A., Boland A., Koivisto A., Daniele A., Greco A., Marianthi A., McGuinness B., Fin B., Ferrari C., Custodero C., Ferrarese C., Ingino C., Mangone C., Reyes Toso C., Cuesta C., Muchnik C., Joachim C., Ortiz C., Besse C., Johansson C., Zoia C.P., Laske C., Anastasiou C., Palacio D.L., Politis D.G., Janowitz D., Craig D., Mann D.M., Neary D., Jürgen D., Daian D., Belezhanska D., Kohler E., Castaño E.M., Koutsouraki E., Chipi E., De Roeck E., Costantini E., Vardy E.R.L.C., Roveta F., Piras F., Prestia F.A., Assogna F., Salani F., Sala G., Lacidogna G., Novack G., Wilcock G., Thonberg H., Kölsch H., Weber H., Boecker H., Etchepareborda I., Piaceri I., Tuomilehto J., Lindström J., Laczo J., Johnston J., Deleuze J.-F., Harris J., Schott J.M., Priller J., Bacha J.I., Snowden J., Lisso J., Mihova K.Y., Traykov L., Morelli L., Brusco L.I., Rainer M., Takalo M., Bjerke M., Del Zompo M., Serpente M., Sanchez Abalos M., Rios M., Peltonen M., Herrman M.J., Kohler M., Rojo M., Jones M., Orsini M., Medel N., Olivar N., Fox N.C., Salvadori N., Hooper N.M., Galeano P., Solis P., Bastiani P., Passmore P., Heun R., Antikainen R., Olaso R., Perneczky R., Germani S., Love S., Mehrabian S., Bagnoli S., Kochen S., Andreoni S., Teipel S., Todd S., Pickering-Brown S., Natunen T., Tegos T., Laatikainen T., Strandberg T., Polvikoski T.M., Matoska V., Ciullo V., Cores V., Solfrizzi V., Lisetti V., Sevillano Z., Abdelnour C., Aguilera N., Alarcon E., Alegret M., Benaque A., Buendia M., Cañabate P., Carracedo A., Corbatón-Anchuelo A., Diego S., Espinosa A., Gailhajenet A., García-González P., Gil S., Guitart M., González-Pérez A., Hernández I., Ibarria M., Lafuente A., Macias J., Maroñas O., Martín E., Martínez M.T., Mauleón A., Montrreal L., Moreno-Grau S., Moreno M., Ortega G., Pancho A., Pelejá E., Pérez-Cordon A., Pineda J.A., Preckler S., Quintela I., Rosende-Roca M., Sanabria A., Serrano-Rios M., Sotolongo-Grau O., Valero S., Vargas L., Adarmes-Gómez A.D., Alarcón-Martín E., Alonso M.D., Álvarez I., Amer-Ferrer G., Antequera M., Antúnez C., Baquero M., Bernal M., Blesa R., Buiza-Rueda D., Burguera J.A., Calero M., Carrillo F., Carrión-Claro M., Casajeros M.J., Cruz-Gamero J.M., de Pancorbo M.M., de Rojas I., del Ser T., Diez-Fairen M., Escuela R., Garrote-Espina L., Fortea J., Franco-Macías E., Frank-García A., Garcia Madrona S., Gómez-Garre P., Hevilla S., Jesús S., Labrador Espinosa M.A., Lage C., Legaz A., López-García S., Macias-García D., Manzanares S., Marín M., Marín-Muñoz J., Marín T., Martín Montes A., Martínez B., Martínez C., Martínez V., Martínez-Lage Álvarez P., Mendioroz Iriarte M., Menéndez-González M., Molinuevo J.L., Pérez Tur J., Periñán-Tocino T., Pineda-Sanchez R., Rábano A., Real de Asúa D., Rodrigo S., Rodríguez-Rodríguez E., Royo J.L., Sanchez del Valle Díaz R., Sastre I., Vicente M.P., Vigo-Ortega R., Vivancos L., Macleod C., McCracken C., Brayne C., Bresner C., Grozeva D., Bellou E., Sommerville E.W., Matthews F., Leonenko G., Menzies G., Windle G., Harwood J., Phillips J., Bennett K., Luckuck L., Clare L., Woods R., Saad S., Burholt V., Rongve A., Kehoe P.G., Garcia-Ribas G., Sánchez-Juan P., Pastor P., Pérez-Tur J., Piñol-Ripoll G., Lopez de Munain A., García-Alberca J.M., Bullido M.J., Álvarez V., Lleó A., Real L.M., Mir P., Medina M., Scheltens P., Holstege H., Marquié M., Sáez M.E., Carracedo Á., Amouyel P., Schellenberg G.D., Williams J., Seshadri S., van Duijn C.M., Mather K.A., Sánchez-Valle R., Serrano-Ríos M., Orellana A., Tárraga L., Blennow K., Huisman M., Andreassen O.A., Posthuma D., Clarimón J., Boada M., van der Flier W.M., Ramirez A., Lambert J.-C., van der Lee S.J., Ruiz A., EADB contributors, IGAP (ADGC, CHARGE, EADI, GERAD), PGC-ALZ consortia. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8). Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-36192-x. PMID:36759603. IF:14.700(Q1/1D).
01/01/2023
Neuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral Sclerosis
de Luna N., Carbayo Á., Dols-Icardo O., Turon-Sans J., Reyes-Leiva D., Illan-Gala I., Jericó I., Pagola-Lorz I., Lleixà C., Querol L., Rubio-Guerra S., Alcolea D., Fortea J., Lleó A., Cortés-Vicente E., Rojas-Garcia R.. Neuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral Sclerosis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(2)DOI:10.1212/NXI.0000000000200072. PMID:36460480. IF:8.300(Q1/1D).
01/01/2023
Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal Dementia
Friedberg A., Pasquini L., Diggs R., Glaubitz E.A., Lopez L., Illán-Gala I., Iaccarino L., La Joie R., Mundada N., Knudtson M., Neylan K., Brown J., Allen I.E., Rankin K.P., Bonham L.W., Yokoyama J.S., Ramos E.M., Geschwind D.H., Spina S., Grinberg L.T., Miller Z.A., Kramer J.H., Rosen H., Gorno-Tempini M.L., Rabinovici G., Seeley W.W., Miller B.L.. Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal Dementia. JAMA Neurology. 2023; 80(4)DOI:10.1001/jamaneurol.2023.0001. PMID:36848111. IF:20.900(Q1/1D).
01/01/2023
Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease
Fortea, J, Garcia-Arcelay, E, Terrancle, A, Galvez, B, Diez-Carreras, V, Rebollo, P, Maurino, J, Garcia-Ribas, G. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(1)DOI:10.3233/JAD-221160. PMID:36970902. IF:3.400(Q2/4D).
01/01/2023
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen
Trifunov S., Natera-De Benito D., Carrera-García L., Codina A., Expósito-Escudero J., Ortez C., Medina J., Alcala, ST, Bernal S., Alias L., Badosa C., Balsells S., Alcolea D., Nascimento A., Jimenez-Mallebrera C.. Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen. Journal Of Neuromuscular Diseases. 2023; 10(4)DOI:10.3233/JND-230012. PMID:37038823. IF:3.200(Q2/3D).
01/01/2023
Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society
Hamlett E.D., Flores-Aguilar L., Handen B., Potier M.-C., Granholm A.-C., Sherman S., Puig V., Santoro J.D., Carmona-Iragui M., Rebillat A.-S., Head E., Strydom A., Busciglio J.. Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society. Molecular Syndromology. 2023; 14(2)DOI:10.1159/000526021. PMID:37064334. IF:0.900(Q4/10D).
01/01/2023
Multifocal Transcranial Direct Current Stimulation in Primary Progressive Aphasia Does Not Provide a Clinical Benefit Over Speech Therapy
Borrego-Écija S., Montagut N., Martín-Trias P., Vaqué-Alcázar L., Illán-Gala I., Balasa M., Lladó A., Casanova-Mollà J., Bargalló N., Valls-Solé J., Lleó A., Bartrés-Faz D., Sánchez-Valle R.. Multifocal Transcranial Direct Current Stimulation in Primary Progressive Aphasia Does Not Provide a Clinical Benefit Over Speech Therapy. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(3)DOI:10.3233/JAD-230069. PMID:37182884. IF:3.400(Q2/4D).
01/01/2023
Compounded inequality: racial disparity and Down syndrome
McGlinchey E., Iulita M.F., Fortea J.. Compounded inequality: racial disparity and Down syndrome. Lancet Public Health. 2023; 8(11)DOI:10.1016/S2468-2667(23)00213-X. PMID:. IF:(Q/D).
01/01/2023
Bilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices
Grasso, SM, Rodríguez, CAW, Colomer, NM, Kiderle, SKM, Sáanchez-Valle, R, Santos, MAS. Bilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices. JOURNAL OF ALZHEIMERS DISEASE. 2023; 96(4)DOI:10.3233/JAD-230673. PMID:37980666. IF:3.400(Q2/4D).
01/12/2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease
Holstege, H, Hulsman, M, Charbonnier, C, Grenier-Boley, B, Quenez, O, Grozeva, D, van Rooij, JGJ, Sims, R, Ahmad, S, Amin, N, Norsworthy, PJ, Dols-Icardo, O, Hummerich, H, Kawalia, A, Amouyel, P, Beecham, GW, Berr, C, Bis, JC, Boland, A, Bossu, P, Bouwman, F, Bras, J, Campion, D, Cochran, JN, Daniele, A, Dartigues, JF, Debette, S, Deleuze, JF, Denning, N, DeStefano, AL, Farrer, LA, Fernandez, MV, Fox, NC, Galimberti, D, Genin, E, Gille, JJP, Le Guen, Y, Guerreiro, R, Haines, JL, Holmes, C, Ikram, MA, Ikram, MK, Jansen, IE, Kraaij, R, Lathrop, M, Lemstra, AW, Lleo, A, Luckcuck, L, Mannens, MMAM, Marshall, R, Martin, ER, Masullo, C, Mayeux, R, Mecocci, P, Meggy, A, Mol, MO, Morgan, K, Myers, RM, Nacmias, B, Naj, AC, Napolioni, V, Pasquier, F, Pastor, P, Pericak-Vance, MA, Raybould, R, Redon, R, Reinders, MJT, Richard, AC, Riedel-Heller, SG, Rivadeneira, F, Rousseau, S, Ryan, NS, Saad, S, Sanchez-Juan, P, Schellenberg, GD, Scheltens, P, Schott, JM, Seripa, D, Seshadri, S, Sie, D, Sistermans, EA, Sorbi, S, van Spaendonk, R, Spalletta, G, Tesi, N, Tijms, B, Uitterlinden, AG, van der Lee, SJ, Visser, PJ, Wagner, M, Wallon, D, Wang, LS, Zarea, A, Clarimon, J, van Swieten, JC, Greicius, MD, Yokoyama, JS, Cruchaga, C, Hardy, J, Ramirez, A, Mead, S, van der Flier, WM, van Duijn, CM, Williams, J, Nicolas, G, Bellenguez, C, Lambert, JC. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease. NATURE GENETICS. 2022; 54(12)DOI:10.1038/s41588-022-01208-7. PMID:36411364. IF:30.800(Q1/1D).
30/11/2022
beta-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease
Mohaupt, P, Pons, ML, Vialaret, J, Delaby, C, Hirtz, C, Lehmann, S. beta-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-01125-1. PMID:36451155. IF:9.000(Q1/1D).
29/11/2022
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
Zhang, YT, Ghose, U, Buckley, NJ, Engelborghs, S, Sleegers, K, Frisoni, GB, Wallin, A, Lleo, A, Popp, J, Martinez-Lage, P, Legido-Quigley, C, Barkhof, F, Zetterberg, H, Visser, PJ, Bertram, L, Lovestone, S, Nevado-Holgado, AJ, Shi, L. Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks. Frontiers in Aging Neuroscience. 2022; 14DOI:10.3389/fnagi.2022.1040001. PMID:36523958. IF:4.800(Q2/3D).
01/09/2022
Neurofilaments: a key new biomarker for clinicians Part 1: Importance of neurofilaments in the management of neurodegenerative diseases
Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments: a key new biomarker for clinicians Part 1: Importance of neurofilaments in the management of neurodegenerative diseases. ANNALES DE BIOLOGIE CLINIQUE. 2022; 80(5)DOI:10.1684/abc.2022.1757. PMID:36453742. IF:0.500(Q4/10D).
01/09/2022
Neurofilaments: a key new biomarker for clinicians Part 2: Neurofilaments, an asset beyond neurodegenerative diseases
Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments: a key new biomarker for clinicians Part 2: Neurofilaments, an asset beyond neurodegenerative diseases. ANNALES DE BIOLOGIE CLINIQUE. 2022; 80(5)DOI:10.1684/abc.2022.1758. PMID:36453743. IF:0.500(Q4/10D).
01/09/2022
Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning Dementia Praecox Revisited
Koutsouleris, N, Pantelis, C, Velakoulis, D, McGuire, P, Dwyer, DB, Urquijo-Castro, MF, Paul, R, Sen Dong, Popovic, D, Oeztuerk, O, Kambeitz, J, Salokangas, RKR, Hietala, J, Bertolino, A, Brambilla, P, Upthegrove, R, Wood, SJ, Lencer, R, Borgwardt, S, Maj, C, Nothen, M, Degenhardt, F, Polyakova, M, Mueller, K, Villringer, A, Danek, A, Fassbender, K, Fliessbach, K, Jahn, H, Kornhuber, J, Landwehrmeyer, B, Anderl-Straub, S, Prudlo, J, Synofzik, M, Wiltfang, J, Riedl, L, Diehl-Schmid, J, Otto, M, Meisenzahl, E, Falkai, P, Schroeter, ML, Lleo A., Int FTD-Genetics Consortium IFGC, German Frontotemporal Lobar Degene. Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning Dementia Praecox Revisited. JAMA Psychiatry. 2022; 79(9)DOI:10.1001/jamapsychiatry.2022.2075. PMID:35921104. IF:25.800(Q1/1D).
23/05/2022
Prion-like alpha-synuclein pathology in the brain of infants with Krabbe disease
Hatton, C, Ghanem, SS, Koss, DJ, Abdi, IY, Gibbons, E, Guerreiro, R, Bras, J, Walker, L, Gelpi, E, Heywood, W, Outeiro, TF, Attems, J, McFarland, R, Forsyth, R, El-Agnaf, OM, Erskine, D, LLEO BISA, ALBERTO, Int DLB Genetics Consortium. Prion-like alpha-synuclein pathology in the brain of infants with Krabbe disease. BRAIN. 2022; 145(4)DOI:10.1093/brain/awac002. PMID:34999780. IF:14.500(Q1/1D).
01/03/2022
Focal Point The crucial history of Down syndrome
Zaman, S, Fortea, J. Focal Point The crucial history of Down syndrome. LANCET NEUROLOGY. 2022; 21(3)DOI:10.1016/S1474-4422(22)00047-3. PMID:35182507. IF:48.000(Q1/1D).
01/01/2022
Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease
Villarejo-Galende, A, Garcia-Arcelay, E, Pinol-Ripoll, G, del Olmo-Rodriguez, A, Vinuela, F, Boada, M, Franco-Macias, E, de la Pena, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodriguez-Rodriguez, E, Vieira-Camposs, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Terrancle, A, Prefasi, D, Lleo, A, Maurino, J. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2022; 90(2)DOI:10.3233/JAD-220696. PMID:36155523. IF:4.000(Q2/4D).
01/01/2022
Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders
Gómez de San José N., Goossens J., Al Shweiki M.R., Halbgebauer S., Oeckl P., Steinacker P., Danzer K.M., Graf H., Schönfeldt-Lecuona C., Belbin O., Lleó A., Vanmechelen E., Otto M.. Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders. JOURNAL OF PSYCHIATRIC RESEARCH. 2022; 156DOI:10.1016/j.jpsychires.2022.10.010. PMID:36323141. IF:4.800(Q2/4D).
01/01/2022
CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels
del Campo M., Peeters C.F.W., Johnson E.C.B., Vermunt L., Hok-A-Hin Y.S., van Nee M., Chen-Plotkin A., Irwin D.J., Hu W.T., Lah J.J., Seyfried N.T., Dammer E.B., Herradon G., Meeter L.H., van Swieten J., Alcolea D., Lleó A., Levey A.I., Lemstra A.W., Pijnenburg Y.A.L., Visser P.J., Tijms B.M., van der Flier W.M., Teunissen C.E.. CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nature Aging. 2022; 2(11)DOI:10.1038/s43587-022-00300-1. PMID:37118088. IF:(Q/D).